Item 5. Market for Registrant’s Common Equity
ITEM
5. MARKET FOR COMPANY’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.
Market
Information
Our
shares of common stock have been quoted on the OTCQB by the OTC Markets Group Inc. of the Financial Industry Regulatory Authority, Inc.
(“FINRA”) under the symbol “LAZX” since May 2019 and “SLBG” since November 2019.
On
July 30, 2021, the stock closed at $3.20.
Holders
of Record
On
July 31, 2021, there were 118 holders of record of our common stock, as reported by the Company’s transfer agent.
In computing the number of holders of record, each broker-dealer and clearing corporation holding shares on behalf of its customers is
counted as a single shareholder.
Dividends
We
have never declared or paid any cash dividends on our common stock nor do we anticipate paying any in the foreseeable future. Furthermore,
we expect to retain any future earnings to finance our operations and expansion. The payment of cash dividends in the future will be
at the discretion of our Board of Directors.
32
Equity
Compensation Plans
On
November 11, 2020, the Board of Directors of the Company approved the Slinger Bag Inc. Global Share Incentive Plan (2020), or the 2020
Plan, which was approved by stockholders holding in the aggregate 19,994,700 shares of the Company’s common stock, or approximately
75.4% of the Company’s common stock outstanding on such date. The 2020 Plan provides for the grant of awards which are incentive
stock options (“ISOs”), non-qualified stock options (“NQSOs”), unrestricted stock, restricted stock, restricted
stock units, performance stock and other equity-based and cash awards or any combination of the foregoing, to eligible key management
employees, non-employee directors, and non-employee consultants of the Company or any of its subsidiaries (each a “participant”)
(however, solely employees of the Company and its subsidiaries are eligible for incentive stock option awards).
The
Company has reserved a total of 15,000,000 shares for issuance under awards to be made under the 2020 Plan, all of which may, but need
not, be issued in connection with ISOs. To the extent that an award lapses, expires, is canceled, is terminated unexercised or ceases
to be exercisable for any reason, or the rights of its holder terminate, any shares subject to such award shall again be available for
the grant of a new award. The 2020 Plan shall continue in effect, unless sooner terminated, until the tenth (10th) anniversary
of the date on which it was adopted by the Board of Directors (except as to awards outstanding on that date). The Board of Directors
in its discretion may terminate the 2020 Plan at any time with respect to any shares for which awards have not theretofore been
granted; provided, however, that the 2020 Plan’s termination shall not materially and adversely impair the rights of a holder,
without the consent of the holder, with respect to any award previously granted.
Future
new hires, non-employee directors and additional non-employee consultants are eligible to participate in the 2020 Plan as well. The number
of awards to be granted to officers, non-employee directors, employees and non-employee consultants cannot be determined at this time
as the grant of awards is dependent upon various factors such as hiring requirements and job performance.
Recent
Sales of Unregistered Securities; Use of Proceeds from Registered Securities
On
April 11, 2021, the Company issued 272,332 shares of its common stock for the conversion and full satisfaction of the Company’s
obligations of a $1,000,000 promissory note.
On
April 11, 2021 and on April 13, 2021, the Company issued 18,750 and 5,000 shares of its common stock to two vendors as compensation for
marketing and advisory services.
On
May 26, 2021, the Company issued 1,636,843 shares of its common stock for the conversion and full satisfaction of the Company’s
$6,220,0000 in notes payable to its related party lender.
On
June 23, 2021, the Company issued 540,000 shares of its common stock in satisfaction of the first tranche related to the Company’s
purchase of Foundation Sports Systems, LLC.
During
the three months ended July 31, 2021, the Company issued 68,965 shares of its common stock to one vendor and two employees as compensation
for marketing and other services rendered.
During
the three months ended July 31, 2021, the Company granted an aggregate total of 90,937 shares of its common stock to six brand ambassadors
as compensation for services.
Issuer
Purchases of Equity Securities
None.
ITEM
6. SELECTED FINANCIAL DATA
Not applicable
to smaller reporting companies.
ITEM
7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Overview
Lazex
Inc. (“Lazex”) was incorporated under the laws of the State of Nevada on July 12, 2015. On August 23, 2019, the majority
owner of Lazex entered into a Stock Purchase Agreement with Slinger Bag Americas Inc., a Delaware corporation (“Slinger Bag Americas”),
which was 100% owned by Slinger Bag Ltd. (“SBL”), an Israeli company. In connection with the Stock Purchase Agreement,
Slinger Bag Americas acquired 20,000,000 shares of common stock of Lazex for $332,239. On September 16, 2019, SBL transferred its ownership
of Slinger Bag Americas to Lazex in exchange for the 20,000,000 shares of Lazex acquired on August 23, 2019. As a result of these transactions,
Lazex owned 100% of Slinger Bag Americas and the sole shareholder of SBL owned 20,000,000 shares of common stock (approximately 82%)
of Lazex. Effective September 13, 2019, Lazex changed its name to Slinger Bag Inc.
On
October 31, 2019, Slinger Bag Americas acquired control of Slinger Bag Canada, Inc., (“Slinger Bag Canada”) a Canadian company
incorporated on November 3, 2017. There were no assets, liabilities or historical operational activity of Slinger Bag Canada.
On
February 10, 2020, Slinger Bag Americas became the 100% owner of SBL, along with SBL’s wholly owned subsidiary Slinger Bag International
(UK) Limited (“Slinger Bag UK”), which was formed on April 3, 2019. On February 10, 2021, Zehava Tepler, the
owner of SBL, contributed Slinger Bag UK to Slinger Bag Americas for no consideration.
The
operations of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK and SBL are collectively referred to
as the “Company.”
The
Company operates in the sporting and athletic goods business. The Company is the owner of the Slinger Launcher, which is a portable tennis
ball launcher, as well as other associated tennis accessories.
Effective
February 25, 2020, the Company increased the number of authorized shares of common stock from 75,000,000 to 300,000,000 via a four-to-one
forward split of its outstanding shares of common stock. All share and per share information contained in this report have been retroactively
adjusted to reflect the impact of the stock split.
33
Critical
Accounting Policies and Estimates
Basis
of Presentation
The
consolidated financial statements of the Company are presented in accordance with accounting principles generally accepted in the United
States of America (“GAAP”). As a result of the transactions described above, the accompanying consolidated financial statements
include the combined results of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK and SBL for the years
ended April 30, 2021 and 2020. The contribution of the net assets of SBL is reflected as an equity contribution at historical
cost on May 1, 2019, the beginning of the earliest period in which the entities were under common control. There was no historical activity
in Slinger Bag Americas or Slinger Bag Canada prior to May 1, 2019. All intercompany accounts and transactions have been eliminated in
consolidation.
Use
of Estimates
The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from
those estimates.
Valuation
of Inventory
Inventory
is valued at the lower of the cost (determined principally on a first-in, first-out basis) or net realizable value. The Company’s
valuation of inventory includes inventory reserves for inventory that will be sold below cost and the impact of inventory shrink. Inventory
reserves are based on historical information and assumptions about future demand and inventory shrink trends. It is possible that changes
to inventory reserve estimates could be required in future periods due to changes in market conditions.
Revenue
Recognition
The
Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606,
the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers
in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.
The Company recognizes revenue for its performance obligation associated with its contracts with customers at a point in time once products
are shipped. Amounts collected from customers in advance of shipping products ordered are reflected as deferred revenue
on the accompanying consolidated balance sheets. The Company’s standard terms are non-cancelable and do not provide for the
right-of-return, other than for defective merchandise covered under the Company’s standard warranty. The Company has not historically
experienced any significant returns or warranty issues.
Fair
Value of Financial Instruments
Fair
value of financial and non-financial assets and liabilities is defined as an exit price, representing the amount that would be received
to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The three-tier hierarchy for
inputs used in measuring fair value, which prioritizes the inputs used in the methodologies of measuring fair value for assets and liabilities,
is as follows:
Level
1 — Quoted prices in active markets for identical assets or liabilities
Level
2 — Observable inputs other than quoted prices in active markets for identical assets and liabilities
Level
3 — Unobservable pricing inputs in the market
Financial
assets and financial liabilities are classified in their entirety based on the lowest level of input that is significant to the fair
value measurements. Our assessment of the significance of a particular input to the fair value measurements requires judgment and may
affect the valuation of the assets and liabilities being measured and their categorization within the fair value hierarchy.
The
Company’s financial instruments consist of cash and cash equivalents, accounts receivable, and accounts payable. The carrying
amount of these financial instruments approximates fair value due to their short-term maturity. The Company’s derivative liabilities
were calculated using Level 2 assumptions.
34
Income
Taxes
Income
taxes are accounted for in accordance with the provisions of ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities
are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation
allowances are established, when necessary, to reduce deferred tax assets to the amounts that are more likely than not to be realized.
Long-Lived
Assets
In
accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate
that their net book value may not be recoverable. When such factors and circumstances exist, the Company compares the projected undiscounted
future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying
amount. If those net undiscounted cash flows do not exceed the carrying amount, impairment, if any, is based on the excess of
the carrying amount over the fair value, based on market value or discounted expected cash flows of those assets and is recorded in the
period in which the determination is made. There was no impairment of long-lived assets identified during the year ended April 30, 2021
or 2020.
Valuation
of Warrants
The
Company grants warrants to key employees and executives as compensation on a discretionary basis. The Company also grants warrants in
connection with certain note payable agreements and other key arrangements. The Company is required to estimate the fair value
of share-based awards on the measurement date and recognize as expense that value of the portion of the award that is ultimately expected
to vest over the requisite service period.
Recent
Accounting Pronouncements
In
December 2019, the FASB issued Accounting Standards Update (ASU), 2019-12, Simplifying the Accounting for Income Taxes , which
amends ASC 740, Income Taxes (ASC 740). This update is intended to simplify accounting for income taxes by removing certain exceptions
to the general principles in ASC 740 and amending existing guidance to improve consistent application of ASC 740. This update is effective
for fiscal years beginning after December 15, 2021. The guidance in this update has various elements, some of which are applied on a
prospective basis and others on a retrospective basis with earlier application permitted. The Company is currently evaluating the effect
of this ASU on the Company’s financial statements and related disclosures.
35
Results
of Operations for the Years Ended April 30, 2021 and 2020
The
following are the results of our operations for the year ended April 30, 2021 as compared to April 30, 2020:
For
the Year Ended
April 30,
April 30,
2021
2020
Change
Net sales
$ 10,804,214
$ 686,179
$ 10,118,035
Cost of sales
7,680,290
1,370,897
6,309,393
Gross income (loss)
3,123,924
(684,718 )
3,808,642
Operating expenses:
Selling and marketing expenses
1,761,154
563,003
1,198,151
General and administrative expenses
4,749,922
5,291,075
(541,153 )
Research and development costs
339,385
179,982
159,403
Transaction costs
-
198,443
(198,443 )
Total
operating expenses
6,850,461
6,232,503
617,958
Loss from operations
(3,726,537 )
(6,917,221 )
3,190,684
Other expenses (income):
Amortization of debt discount
376,506
1,565,174
(1,188,668 )
Loss on extinguishment of debt
3,030,495
-
3,030,495
Induced conversion loss
51,412
-
51,412
Gain on change in fair value of derivatives
(1,939,639 )
-
(1,939,639 )
Interest expense - related party
608,668
171,918
436,750
Interest expense
12,740,781
573,431
12,167,350
Total
other expense
14,868,223
2,310,523
12,557,700
Loss before income taxes
(18,594,760 )
(9,227,744 )
(9,367,016 )
Provision for income
taxes
-
-
-
Net loss
$ (18,594,760 )
$ (9,227,744 )
$ (9,367,016 )
Net
sales
Our
net sales during the year ended April 30, 2021 were $10,804,214,
which consisted partially of shipped orders related to our Kickstarter and Indiegogo crowdfunding campaigns initiated in fiscal year
2019, as well as new orders placed and fulfilled to consumers via our online marketplace and to our international distributors. Our net
sales during the year ended April 30, 2020 were $686,179 and were entirely related to our crowdfunding campaigns. As of April 30,
2021 and April 30, 2020, we had deferred revenue of $99,531 and $179,366, respectively, representing units that have not
been shipped at year end.
36
Cost
of sales
Our
cost of sales during the year ended April 30, 2021 were $7,680,290, which represents the costs of units shipped during the period, and
resulted in a gross profit of $3,123,924, or 29%. During the first quarter of the current year, we experienced a gross loss as the bulk
of our sales in that period related to the shipment of initial crowdfunding orders. The loss on these shipments was due to (1) discounted
pricing on the initial crowdfunding orders, (2) as fulfillment was later than initially scheduled we fulfilled orders with the “deluxe”
version of launcher (including all features), as well as tennis balls, both of which increased costs, and (3) due to sanctions by the
U.S. against Chinese sourced products, the import duty was raised on all launchers brought into the U.S. increasing our cost of sales.
As a result, our cost of sales exceeded initial sales values raised in our crowdfunding campaigns. As of the beginning of the third quarter,
substantially all of the initial crowdfunding orders had been fulfilled. Sales generated during the last two fiscal quarters represented
new orders placed and fulfilled during the current year by consumers and distributors, which resulted in a positive gross profit. Currently,
our cost of sales is being negatively impacted by the large increase in container costs out of Asia. Our cost of sales during the year
ended April 30, 2020 were $1,370,897, and resulted in a gross loss of $684,718 for the reasons stated above relating to our crowdfunding
orders.
Selling
and marketing expenses
During
the year ended April 30, 2021, we incurred selling and marketing expenses of $1,761,154 compared with $563,003 during the year ended
April 30, 2020. This increase is largely driven by an increase in social media advertising, sponsorships, and other investments in our
public relations presence in order to drive sales and build brand awareness.
General
and administrative expenses
General
and administrative expenses consist primarily of compensation, including share-based compensation, and other employee-related costs,
as well as legal fees and fees for professional services. During the year ended April 30, 2021, we incurred general and administrative
expenses of $4,749,922 compared with $5,291,075 during the year ended April 30, 2020. The decrease in general and administrative expenses
is largely due to a one-time warrant grant to key employees and officers of the Company in the prior year that resulted in an expense
of $3,741,746, which was partially offset in the current year by an increase in compensation expense due to increased headcount as a
result of the continued growth of the business.
Research
and development costs
During
the year ended April 30, 2021, we incurred research and development costs of $339,385 compared with $179,982 during the year ended April
30, 2020. This increase is mainly driven by our investment in a new platform and app that will integrate artificial intelligence (AI)
technology to offer more value to our customers.
Transaction
costs
During
the year ended April 30, 2020, we incurred transaction costs associated with completing the Stock Purchase Agreement with Slinger Bag
Americas, as well as additional professional fees associated with being a publicly traded company.
Other
expenses
During
the years ended April 30, 2021 and April 30, 2020, we had other expenses totaling $14,868,223 and $2,310,523, respectively.
The increase in other expenses for the year ended April 30, 2021 as compared to April 30, 2020 was primarily due to increases in loss
on extinguishment of debt of $3,030,495 and induced conversion loss of $51,412 due to debt extinguishment transactions during the year,
increases in related party interest expense due to the increase in related party note payable balances during the year, and the increase
in interest expense due to the $12,501,178 charge related to the warrants and make-whole provision that were issued in conjunction with
a note payable that was entered into during the year. These increases were partially offset by decreases in amortization of debt discount
of $1,188,668 and the gain on the change in fair value of derivatives for the year ended April 30, 2021 of $1,939,639.
Liquidity
and Capital Resources
Our
financial statements have been prepared on a going concern basis, which assumes we will be able to realize our assets and discharge
our liabilities in the normal course of business for the foreseeable future. We had an accumulated deficit of $28,823,273 as of April
30, 2021, and more losses are anticipated in the development of the business. Accordingly, there is substantial doubt about our ability
to continue as a going concern. Our financial statements do not include any adjustments related to the recoverability and classification
of assets or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.
The
ability to continue as a going concern is dependent upon our generating profitable operations in the future and/or being able to obtain
the necessary financing to meet our obligations and repay our liabilities arising from normal business operations when they become due.
Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from related parties, and/or
private placement of debt and/or common stock.
The
following is a summary of our cash flows from operating, investing and financing activities for the years ended April 30, 2021
and 2020:
For
the Year Ended
April
30,
April
30,
2021
2020
Cash
flows from operating activities
$
(4,517,457
)
$
(4,208,274
)
Cash
flows from investing activities
$
(30,000
)
$
73,400
Cash
flows from financing activities
$
5,420,000
$
4,217,761
We
had cash and cash equivalents of $928,796 as of April 30, 2021, as compared to $79,847 as of April 30, 2020.
Net
cash used in operating activities was $4,517,457 during the year ended April 30, 2021, compared with $4,208,274 during the
year ended April 30, 2020. Our cash used in operating activities during the year ended April 30, 2021 was primarily the result of our
net loss of $18,594,760 for the year as well as increases in inventory and accounts receivable year over year, which was partially offset
by non-cash expenses of $14,892,030 and increases in accounts payable and accrued expenses, accrued payroll and bonuses and accrued interest
– related party as well as a decrease in prepaid expenses and other current assets year over year. Our net cash used in operating
activities during year ended April 30, 2020 was primarily the result of our net loss of $9,227,744 during the year as well as increases
in inventory and prepaid expenses and other current assets, which was partially offset by non-cash expenses of $5,666,425 as well as
increases in accounts payable and accrued expenses, accrued payroll and bonuses and accrued interest – related party.
37
Net
cash used in investing activities was $30,000 for the year ended April 30, 2021, compared with net cash provided by
investing activities of $73,400 for the for year ended April 30, 2020. Investing activities for the year ended April 30, 2021
related to the purchase of the Slinger trademark, while investing activities for the year ended April 30, 2020 were the result of $73,400
in cash we acquired from the contribution of the net assets of Slinger Bag Limited.
Net
cash provided by financing activities was $5,420,000 for the year ended April 30, 2021, compared with $4,217,761 for the year
ended April 30, 2020. Cash provided by financing activities for the year ended April 30, 2021 consisted of proceeds of $3,300,000
from notes payable with a related party, proceeds of $3,120,000 from notes payable, and a repayment of notes payable with a related
party of $1,000,000. Cash provided by financing activities for the year ended April 30, 2020 consisted of proceeds of
$2,100,000 from notes payable with a related party, $1,950,000 in proceeds from convertible notes payable, and proceeds of $500,000
from a note payable, which was partially offset by a distribution to the majority shareholder for $332,239.
Description
of Indebtedness
Notes
Payable – Related Party
On
October 1, 2019, the Company entered into a loan agreement with a related party entity controlled by the former shareholder of
Slinger Bag Canada for borrowings of $500,000 bearing interest at 12% per annum. All principal and accrued interest were due on demand
under the original agreement. On December 13, 2019, the Company entered into an Amended and Restated Loan Agreement making all
principal and accrued interest due on July 15, 2020, which was later amended to extend the due date to September 1, 2021.
On
December 3, 2019, the Company entered into a loan agreement with the same related party for borrowings of $500,000 bearing interest at
12% per annum. All principal and accrued interest were due on demand under the original agreement. On December 13, 2019, the Company
entered into an Amended and Restated Loan Agreement increasing the interest rate earned from 12% to 24% per annum and making all principal
and accrued interest due on July 15, 2020, which was later amended to extend the due date to September 1, 2021.
On
December 11, 2019, the Company entered into a loan agreement with the same related party for borrowings of $700,000 bearing interest
at 24% per annum. All principal and accrued interest were due on July 15, 2020. On July 8, 2020, the terms of the debt were amended
to extend the due date to January 8, 2021, which was later amended to extend the due date to September 1, 2021.
On
January 6, 2019, the Company entered into a loan agreement with the same related party for borrowings of $200,000 bearing interest at
24% per annum. All principal and accrued interest were due on January 8, 2021, which was later amended to extend the due date to September
1, 2021.
On
February 28, 2020, the Company entered into a loan agreement with the same related party for borrowings of $200,000 bearing interest
at 24% per annum. All principal and accrued interest were due on February 28, 2021, which was later amended to extend the due
date to September 1, 2021.
On
May 12, 2020 and July 3, 2020, the Company entered into loan agreements with the same related party for borrowings of $1,000,000
and $500,000, respectively, bearing interest at 24% per annum. All principal and accrued interest were due on August
31, 2020 and July 3, 2021, respectively, which was later amended to extend the due dates to September 1, 2021.
On
July 8, 2020, the Company entered into a Purchase Order Financing Agreement (“PO Financing Agreement”) whereby $1,900,000
of the total $3,600,000 in outstanding debt due to the related party as of the date of the agreement was labeled as inventory
financing (“PO Financing Amount”). The PO Financing Amount, along with any accrued interest, is due in full no later than
six months from the effective date of the PO Financing Agreement, which was later amended to extend the due date to September 1, 2021.
The outstanding balance of the PO Financing Amount bears interest at a rate of 2% per month. The Company agreed to repay the PO Financing
Amount together with any accrued, but unpaid, interest thereon out of proceeds from the sale of its products, licensing activities,
revenue to be generated from operations and/or amounts received by the Company from investors, lenders, financiers, financing sources
or other persons before making payments of any other nature (including dividends and distributions), except for payments required
to finance the Company’s operations.
On
August 10, 2020, the Company entered into a loan agreement with the same related party for borrowings of $250,000 under
the PO Financing Agreement bearing interest at 24% per annum. All principal and accrued interest were due on August 10, 2021, which
was later amended to extend the due date to September 1, 2021.
38
On
September 7, 2020, the outstanding debt from the existing related party lender was amended to reduce the interest rate to 9.5%
per annum on all outstanding loans, including the PO Financing Agreement, effective the date of the agreement. As consideration
for agreeing to reduce the interest rate, the Company issued the related party warrants to purchase 2,500,000 shares of the Company’s
common stock at an exercise of $0.001 per share. The warrants vest immediately and have a contractual life of 10 years.
On
September 8, 2020, the existing related party lender agreed to extend the due date of all outstanding loans to September 1, 2021.
On
September 15, 2020, the Company entered into a loan agreement with the same related party for borrowings of $250,000 bearing
interest at 9.5% per annum and due in full on September 15, 2021. In connection with the loan, the Company issued warrants to the
related party lender to purchase 125,000 shares of the Company’s common stock at an exercise price of $0.001 per share.
The warrants vest immediately and have a contractual life of 10 years. The note was discounted by $70,130 allocated from the valuation
of the warrants issued. The discount recorded on the note is being amortized through the maturity date, which amounted to $43,615
for the year ended April 30, 2021. As of April 30, 2021, the remaining discount was $26,515.
On
November 24, 2020, the Company entered into a loan agreement with the same related party for borrowings of $300,000 bearing
interest at 9.5% per annum and due in full on November 24, 2021. In connection with the loan, the Company issued warrants to the
related party lender to purchase 125,000 shares of the Company’s common stock at an exercise price of $0.001 per share.
The warrants vest immediately and have a contractual life of 10 years. This note was discounted by $88,201 allocated from the
valuation of the warrants issued. The discount recorded on the note is being amortized through the maturity date, which amounted to
$37,939 for the year ended April 30, 2021. As of April 30, 2021, the remaining discount was $50,262.
On
December 3, 2020, Mont-Saic Investments LLC (“Mont-Saic”) entered into an Assignment and Conveyance Agreement
with 2490585 Ontario Inc., the Company’s existing related party lender (“2490585 Ontario”). In connection with the
agreement, Mont-Saic sold its full right, title and interest in its outstanding notes payable amounting to $1,820,000 to 2490585
Ontario, Inc., along with the 1,216,560 shares of common stock previously issued to Mont-Saic in connection with the debt agreement
and the rights to receive the remaining 6,921,299 shares issuable. Subsequent to this point in time, the outstanding debt of $1,820,000
and all accrued interest is payable to 2490585 Ontario and future interest will accrue at a rate of 9.5% per annum consistent with the
rate being charged on their other outstanding debt. The scheduled maturity date of the debt remains unchanged and is due June 1, 2021.
As of April 30, 2021, there remain 6,921,299 shares issuable related to this note.
On
April 1, 2021, 2490585 Ontario transferred 100% of its right, title and interest in, to and under its loan agreements with the Company
in the aggregate amount of $6,220,000, its 1,216,560 shares of common stock and right to receive an additional 6,921,299 shares
of the Company’s common stock to 2672237 Ontario Ltd. (“2672237 Ontario”), an affiliated Company of 2490585
Ontario.
Total
outstanding borrowings from the related party lender as of April 30, 2021 and 2020 amounted to $6,220,000 and $2,100,000,
respectively. The outstanding amount is net of total discounts of $76,777 for a net book value of $6,143,223 as of April 30, 2021.
Interest
expense related to this related party for the years ended April 30, 2021 and April 30, 2020 amounted to $608,668
and $171,918, respectively. Accrued interest due to this related party as of April 30, 2021 and April 30, 2020 amounted to $747,636
and $138,967, respectively.
Convertible
Notes Payable
On
June 1, 2019, the Company entered into a convertible note payable agreement with Mont-Saic which provided for borrowings
of $1,700,000 bearing interest at a rate of 12.6% per annum. All outstanding amounts were due on the maturity date 360 days after
the loan issue date. The Company may repay up to 50% of the outstanding balance on the loan prior to the maturity date at their discretion.
The outstanding principal and accrued interest are convertible into shares of the Company’s common stock at any time at the option
of the debtholder at a conversion price equal to 75% of the lowest closing price of the common stock as defined in the agreement. Effective
June 1, 2020, the Company and Mont-Saic amended the terms of the convertible note payable agreement to remove the conversion
rights described above and to extend the maturity date to June 1, 2021. On June 30, 2020, the Company entered into a loan agreement
with Mont-Saic to borrow an additional $120,000, bearing interest at 12.6% per annum and due in full on June 30, 2021.
On
December 3, 2020, Mont-Saic entered into an Assignment and Conveyance Agreement with the Company’s exiting related party lender
wherein Mont-Saic sold its full right, title and interest in its outstanding notes payable amounting to $1,820,000 to the Company’s
related party lender, along with the 1,216,560 shares of common stock previously issued to Mont-Saic in connection with the debt agreement
and the rights to receive the remaining 6,921,299 shares issuable.
39
On
November 20, 2019, the Company entered into a convertible note payable agreement for borrowings of $125,000 bearing interest at 12% per
annum. All outstanding borrowings and accrued interest are due on November 20, 2020. The outstanding principal and accrued interest are
convertible into shares of the Company’s common stock at any time at the option of the debtholder at a conversion price equal to
70% of the lowest closing price of the common stock as defined in the agreement. On March 2, 2020, the holder of the outstanding convertible
note payable elected to convert the outstanding principal of $125,000 and accrued interest of $4,274 into 369,354 shares of the Company’s
common stock in accordance with the terms in the agreement. The remaining balance outstanding was $0 at April 30, 2020.
On
February 11, 2020, the Company entered into a convertible note payable agreement for borrowings of $125,000 bearing interest at 12% per
annum. All outstanding borrowings and accrued interest are due on February 11, 2021. The outstanding principal and accrued interest are
convertible into shares of the Company’s common stock at any time at the option of the debtholder at a conversion price equal to
70% of the lowest closing price of the common stock as defined in the agreement. On September 4, 2020, the holder of this convertible
note elected to convert the total amount of outstanding principal and accrued interest balance into 300,000 shares of the Company’s
common stock.
Total
outstanding principal of convertible notes payable at April 30, 2021 and April 30, 2020 amounted to $0 and $1,825,000, respectively.
The outstanding balances are netted with debt discounts at April 30, 2021 and 2020 of zero and $248,933, respectively.
Note
Payable
On
March 16, 2020, the Company entered into a promissory note payable whereby the Company borrowed $500,000 bearing interest at 12% per
annum. Interest on the note is payable monthly and outstanding principal on the note is due in full on March 16, 2022. On December 15,
2020, the lender converted 100% of the principal amount of the note into 500,000 shares of the Company’s common stock. All accrued
interest had been paid through such date and, so, upon conversion, the note was terminated.
On
December 24, 2020, the Company entered into a promissory note with a third-party to borrow $1,000,000. The promissory note bore interest
at 2.25% and was due February 8, 2021. On February 2, 2021, the Company and the third-party entered into an amendment to extend the promissory
note to April 30, 2021. On April 11, 2021, the Company and the lender entered into an agreement whereby the lender converted the promissory
note into 272,332 shares of Company stock, which were issued to the lender at a 20% discount from the closing price of the stock on the
day prior to the conversion.
On
April 15, 2021, the Company and its subsidiaries, Slinger
Bag Americas Inc., (“SBA”), Slinger Bag Canada, Inc., (“SBC”), Slinger Bag International (UK) Limited (“SB
UK”), and Slinger Bag Ltd., (“SBL” and, together with the Company, SBA, SBC, SB UK, SBL the “Borrower”)
issued a $2,000,000 secured term promissory note that bears interest at the rate of 15% per annum (the “Note”) to SB Invesco
LLC, a Wyoming limited liability company (the “Lender”). In connection with the Note, the Borrower and Lender entered into
the following agreements:
(i)
business
loan and security agreement (“BLSA”);
(ii)
intellectual
property security agreement (“IPSA”);
(iii)
stock
pledge agreement (“SPA”);
(iv)
intercreditor
agreement (“ICA”);
(v)
warrant
purchase agreement (“WPA”); and
(vi)
2,200,000
warrants to the Lender and Chessler Holdings, LLC to purchase shares of common stock of SBI (“Warrants”) and, collectively,
the “Loan Agreements”).
BLSA
Pursuant
to the BLSA, the Borrower granted to the Lender, as collateral security for the payment and performance of all of the obligations and
liabilities of any member of and all of the Borrower in favor of the Lender (the “Obligations”), due or to become due, existing
or hereafter incurred, contracted or acquired, a first priority continuing security interest in all of the assets and personal property
of the Borrower and its business (the “Collateral”). Such security interest is a first priority security interest in the
Collateral.
Upon
the occurrence of an Event of Default (as defined in the BLSA), the Lender may (i) at any time thereafter, in its discretion transfer
any securities or other property constituting Collateral into its own name or that of its nominee and receive the income thereon and
hold the same as security for all Obligations or apply it on any or all amounts due on the Obligations in such order as Lender may elect
in its sole discretion, (ii) enter the Borrower’s premises and take control of its business and (iii) require each Borrower to
establish, at Borrower’s expense, a lock box account with such bank acceptable to Lender, into which Borrower shall promptly deposit
and direct their account debtors to directly remit all payments on receivables and which such payments or deposits shall be the property
solely of the Lender.
40
IPSA
To
secure the prompt payment to the Lender of the Obligations of the Borrower, the Borrower pledged and granted to the Lender a continuing
security interest in and lien upon all of Borrower’s right, title and interest in, to and under the following, whether presently
existing or hereafter created or acquired (collectively, the “ IP Collateral ”):
a.
trademarks and trademark licenses to which the Borrower is a party;
b.
patents and patent licenses to which Borrower is a party;
c.
copyrights and copyright licenses to which Borrower is a party;
d.
intellectual property not covered by the foregoing;
e.
rights to sue third parties for past, present or future infringement, dilution, misappropriation, or other violation of rights in any
intellectual property, including injury to the goodwill associated with any trademark, and all causes of action for the same; and
f.
All proceeds of all or any of the foregoing, tort claims and all claims and other rights to payment including (i) insurance claims against
third parties for loss of, damage to, or destruction of, the foregoing IP Collateral and (ii) payments due or to become due under copyright
licenses, patent licenses or trademark licenses and proceeds payable under, or unearned premiums with respect to, policies of insurance
in whatever form regarding the foregoing Collateral.
SPA
Pursuant
to the SPA, SBI pledged, assigned and granted to the Lender and created a continuing first priority lien and security interest in favor
of the Lender in and to all of its right, title, and interest in and to the following, property (collectively, the “Security Collateral”)
to secure the due and prompt payment and performance of the Borrower’s Obligations:
(a)
100% of the shares in each of its subsidiaries SBA, SBC, SB UK and SBL; and
(b)
all proceeds and products of the foregoing, all books and records relating to the foregoing, all supporting obligations related thereto,
and all accessions to, substitutions, and replacements for, and profits and products of, each of the foregoing, and any and all proceeds
of any insurance, indemnity, warranty, or guaranty payable to the Borrower from time to time with respect to any of the foregoing.
The
Borrower also agreed, from time to time, as may be required by the Lender with respect to all Security Collateral, to take all actions
as may be requested by the Lender to perfect the security interest of the Lender in the Security Collateral and so that control of such
Security Collateral is obtained and at all times held by the Lender.
The
Borrower further authorized the Lender at any time and from time to time to file in any relevant jurisdiction any financing statements
and amendments thereto that contain the information required by Article 9 of the UCC of each applicable jurisdiction for the filing of
any financing statement or amendment relating to the Security Collateral, without the signature of the Borrower where permitted by law.
ICA
Under
the ICA, until the obligations, liabilities and indebtedness of every nature of the Borrower from time to time owed to the Lender under
the Loan Agreements (the “First Lien Obligations”) have been paid in full, any other creditor’s security interest in
and lien on the Collateral to secure the payment and performance of their obligations were subordinated to the Lender’s security
interests in and liens on the Collateral to secure the First Lien Obligations, regardless of the order or time of attachment, or the
order, time, or manner of perfection, or the order or time of filing or recordation of any document or instrument, or other method of
perfecting a lien.
41
WPA
Pursuant
to the WPA, SBI issued and sold to the Lender 2,000,000 warrants to purchase common stock of SBI and to Chessler Holdings, LLC 200,000
warrants to purchase common stock of SBI (together, the “Warrants”).
Warrants
Each
Warrant permits its holder to purchase shares of SBI’s common stock at an exercise price of $0.025 per share, subject to the option
to cashless exercise such warrants.
Each
warrant has other customary terms found in like instruments, including, but not limited to, events of default.
Future
amounts due as of April 30, 2021 are summarized as follows:
Payments
due by period
Total
Less
than
1
year
1-3
years
3-5
years
More
than
5
years
Notes
Payable - Related Party
$ 6,220,000
$ 6,220,000
$ -
$ -
$ -
Note
Payable
$ 2,000,000
$ -
$ 2,000,000
$ -
$ -
Total
$ 8,220,000
$ 6,220,000
$ 2,000,000
$ -
$ -
We
expect that working capital requirements will continue to be funded through a combination of our existing funds, cash flows from operations
and further issuances of debt and/or securities. Our working capital requirements are expected to increase in line with the growth
of our business.
Existing
working capital, further advances and debt instruments, and anticipated cash flow are expected to be adequate to fund our operations
over the next twelve months. We have no lines of credit or other bank financing arrangements. Generally, we have financed operations
to date through the proceeds of the private placement of equity and debt instruments. In connection with our business plan, management
anticipates additional increases in operating expenses and capital expenditures relating to (i) acquisition of inventory; (ii) developmental
expenses associated with a start-up business; and (iii) marketing expenses. We intend to finance these expenses with further issuances
of securities and debt issuances. Thereafter, we expect we will need to raise additional capital and generate revenues to meet long-term
operating requirements. Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders.
Further, such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available
upon acceptable terms, or at all. If adequate funds are not available or not available on acceptable terms, we may not be able to take
advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations.
Off-Balance
Sheet Arrangements
We
have no off-balance sheet arrangements.
Effect
of Inflation and Changes in Prices
We do not
believe that inflation and changes in prices will have a material effect on our operations.
ITEM
7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
As
a smaller reporting company, we are not required to provide this information.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.